Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

about

Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

Item

http://www.wikidata.org/entity/Q38671410

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

@en

type

Item

label

Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

@en

prefLabel

Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

@en

P1476

Hepatic JAK2 protects against atherosclerosis through circulating IGF-1

@en

P2093

Adam H Metherel

http://www.w3.org/2001/XMLSchema#string

Alex P Kitson

http://www.w3.org/2001/XMLSchema#string

Angela Li

http://www.w3.org/2001/XMLSchema#string

Clinton S Robbins

http://www.w3.org/2001/XMLSchema#string

Cynthia T Luk

http://www.w3.org/2001/XMLSchema#string

Jara J Brunt

http://www.w3.org/2001/XMLSchema#string

Joshua Lopes

http://www.w3.org/2001/XMLSchema#string

Michelle P Bendeck

http://www.w3.org/2001/XMLSchema#string

Minna Woo

http://www.w3.org/2001/XMLSchema#string

Richard P Bazinet

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis — An Inflammatory Disease

JAK2 activation by growth hormone and other cytokines

Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime

Hepatic Hedgehog signaling contributes to the regulation of IGF1 and IGFBP1 serum levels

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice.

Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice.

P31

scholarly article

P356

10.1172/JCI.INSIGHT.93735

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David W Dodington

K-U Wagner

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28724798

http://www.w3.org/2001/XMLSchema#string

P932

5518558

http://www.w3.org/2001/XMLSchema#string